revise provisions related to pharmacy and to increase fees.

Reordered and renumbered statutory definitions to improve clarity and organization within the pharmacy law chapter.

Updated the definition of 'interchangeable biological product' to reference current federal standards and January 1, 2018 as the baseline date for regulatory determinations.

Expanded the definition of 'drug utilization review program' to include specific clinical review categories such as therapeutic duplication, drug-disease contraindications, and drug-drug interactions.

Clarified the definition of 'drug administration' to explicitly include injection, inhalation, ingestion, and other means of drug delivery to patients or research subjects.

Updated the definition of 'compounding' to clarify that it includes preparation in anticipation of prescriptions based on routine prescribing patterns, not just existing orders.

Added authority for schools to acquire and maintain epinephrine auto-injectors for emergency allergic reactions without being subject to standard prescription requirements.

Reordered and renumbered statutory definitions in the pharmacy chapter to correct numbering errors and update terminology for biological products and drug devices.

Updated the definition of 'biological product' to reference the 42 U.S.C. § 262(i) definition as of January 1, 2018.

Added definition for 'interchangeable biological product' to clarify FDA standards for biological product interchangeability.

Clarified the definition of 'drug device' to include equipment, processes, and biotechnological entities used with drugs for medication management.

Schools are now authorized to acquire and maintain epinephrine auto-injectors when prescribed by a healthcare provider for emergency treatment of severe allergic reactions causing anaphylaxis.

Updated the definition of 'biological product' to reference the federal definition as of January 1, 2018, and added new definition for 'interchangeable biological product' referencing FDA standards.

Reordered and renumbered several definitions in the pharmacy chapter, including 'Association', 'Board', 'Brand name', 'Compounding', 'Delivery', 'Dispense', 'Distributing', 'Drug administration', 'Drug device', 'Drug utilization review program', 'Equivalent drug product', and 'Interchangeable biological product'.